Literature DB >> 12814267

Structural and functional properties of IL-4delta2, an alternative splice variant of human IL-4.

Anatoly M Vasiliev1, Raisa N Vasilenko, Nataly L Kulikova, Sergey M Andreev, Irina O Chikileva, Galina Yu Puchkova, Igor V Kosarev, Anna V Khodyakova, Valentin S Khlebnikov, Leonid R Ptitsyn, Grygory Ya Shcherbakov, Vladimir N Uversky, Lawrence M DuBuske, Vyacheslav M Abramov.   

Abstract

Structural and functional properties of recombinant IL-4delta2, a naturally occurring splice variant of human IL-4 with a deletion of the loop region 22-37, have been analyzed. IL-4delta2 has alpha-helical structure and most likely preserves the "up-up-down-down" topology typical of the four-helix-bundle cytokines. IL-4delta2 interacts specifically with the alpha chain of IL-4R and competes effectively with IL-4 for the common binding sites. Thus, IL-4delta2 may act as a regulator of the cytokine net, being the natural antagonist of IL-4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814267     DOI: 10.1021/pr025586y

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  9 in total

1.  Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma.

Authors:  Irina G Luzina; Virginia Lockatell; Sachin Lavania; Edward M Pickering; Phillip H Kang; Yulia N Bashkatova; Sergey M Andreev; Sergei P Atamas
Journal:  Cytokine       Date:  2012-01-15       Impact factor: 3.861

2.  Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.

Authors:  Rogelio Hernández-Pando; Diana Aguilar; Hector Orozco; Yuriria Cortez; Laura Rosa Brunet; Graham A Rook
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

3.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

4.  Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation.

Authors:  Helen A Fletcher; Patrick Owiafe; David Jeffries; Philip Hill; Graham A W Rook; Alimuddin Zumla; T Mark Doherty; Roger H Brookes
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

5.  Differential expression of interleukin-4 (IL-4) and IL-4 delta 2 mRNA, but not transforming growth factor beta (TGF-beta), TGF-beta RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment.

Authors:  Joel Fleury Djoba Siawaya; Nchinya Bennedict Bapela; Katharina Ronacher; Nulda Beyers; Paul van Helden; Gerhard Walzl
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

6.  Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169.

Authors:  Yi-Ling Lin; Pei-Ching Chang; Yixiang Wang; Mengtao Li
Journal:  Virus Res       Date:  2007-11-05       Impact factor: 3.303

7.  Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells.

Authors:  Jaydeep Bhat; Justyna Sosna; Jürgen Fritsch; Elgar Susanne Quabius; Stefan Schütze; Sebastian Zeissig; Ole Ammerpohl; Dieter Adam; Dieter Kabelitz
Journal:  Oncotarget       Date:  2016-10-04

8.  Anti-Inflammatory Effects of the Bioactive Compound Ferulic Acid Contained in Oldenlandia diffusa on Collagen-Induced Arthritis in Rats.

Authors:  Hao Zhu; Qing-Hua Liang; Xin-Gui Xiong; Jiang Chen; Dan Wu; Yang Wang; Bo Yang; Yang Zhang; Yong Zhang; Xi Huang
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-04       Impact factor: 2.629

9.  Identification of a novel splice variant for mouse and human interleukin-5.

Authors:  Igor Shilovskiy; Sergei Andreev; Dmitriy Mazurov; Ekaterina Barvinskaia; Svetlana Bolotova; Alexander Nikolskii; Ilya Sergeev; Artem Maerle; Dmitrii Kudlay; Musa Khaitov
Journal:  Heliyon       Date:  2020-03-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.